Page 1171 - Williams Hematology ( PDFDrive )

1146 Part IX: Lymphocytes and Plasma Cells

31. Bessis MC: Ultrastructure of lymphoid and plasma cells in relation to globulin and 63. Crumpton MJ, Snary D: Preparation and properties of lymphocyte plasma membrane.
antibody formation. Lab Invest 10:1040–1067, 1961. Contemp Top Mol Immunol 3:27–56, 1974.
32. Adams B, Dörfler P, Aguzzi A, et al: Pax-5 encodes the transcription factor BSAP and 64. Goppelt M, Eichhorn R, Krebs G, Resch K: Lipid composition of functional domains of
is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev 6: the lymphocyte plasma membrane. Biochim Biophys Acta 854:184–190, 1986.
1589–1607, 1992. 65. Johnson SM, Robinson R: The composition and fluidity of normal and leukaemic or
33. Urbanek P, Wang ZQ, Fetka I, et al: Complete block of early B cell differentiation lymphomatous lymphocyte plasma membranes in mouse and man. Biochim Biophys
and altered patterning of the posterior midbrain in mice lacking Pax5/BSAP. Cell 79: Acta 558:282–295, 1979.
901–912, 1994. 66. Jury EC, Flores-Borja F, Kabouridis PS: Lipid rafts in T cell signalling and disease.
34. Karras JG, Wang Z, Huo L, et al: Signal transducer and activator of transcription-3 Semin Cell Dev Biol 18:608–615, 2007.
(STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly 67. Gupta N, DeFranco AL: Lipid rafts and B cell signaling. Semin Cell Dev Biol 18:
expressed in conventional B lymphocytes. J Exp Med 185:1035–1042, 1997. 616–626, 2007.
35. Kipps TJ: The CD5 B cell. Adv Immunol 47:117–185, 1989. 68. Landry A, Xavier R: Isolation and analysis of lipid rafts in cell-cell interactions. Methods
36. Defrance T, Vanbervliet B, Durand I, et al: Proliferation and differentiation of human Mol Biol 341:251–282, 2006.
CD5+ and CD5– B cell subsets activated through their antigen receptors or CD40 anti- 69. Colgan SP, Eltzschig HK, Eckle T, Thompson LF: Physiological roles for ecto-5′-nucle-
gens. Eur J Immunol 22:2831–2839, 1992. otidase (CD73). Purinergic Signal 2:351–360, 2006.
37. Durandy A, Thuillier L, Forveille M, Fischer A: Phenotypic and functional characteris- 70. Havre PA, Abe M, Urasaki Y, et al: The role of CD26/dipeptidyl peptidase IV in cancer.
tics of human newborns’ B lymphocytes. J Immunol 144:60–65, 1990. Front Biosci 13:1634–1645, 2008.
38. Caligaris-Cappio F, Gobbi M, Bofill M, Janossy G: Infrequent normal B lymphocytes 71. Kameoka J, Tanaka T, Nojima Y, et al: Direct association of adenosine deaminase with
express features of B-chronic lymphocytic leukemia. J Exp Med 155:623–628, 1982. a T cell activation antigen, CD26. Science 261:466–469, 1993.
39. Casali P, Prabhakar BS, Notkins AL: Characterization of multireactive autoantibodies 72. Ohtsuki T, Tsuda H, Morimoto C: Good or evil: CD26 and HIV infection. J Dermatol
and identification of Leu-1+ B lymphocytes as cells making antibodies binding multiple Sci 22:152–160, 2000.
self and exogenous molecules. Int Rev Immunol 3:17–45, 1988. 73. Swennen EL, Coolen EJ, Arts IC, et al: Time-dependent effects of ATP and its deg-
40. Hayakawa K, Hardy RR, Honda M, et al: Ly-1 B cells: Functionally distinct lymphocytes radation products on inflammatory markers in human blood ex vivo. Immunobiology
that secrete IgM autoantibodies. Proc Natl Acad Sci U S A 81:2494–2498, 1984. 213:389–397, 2008.
41. Sthoeger ZM, Wakai M, Tse DB, et al: Production of autoantibodies by CD5-express- 74. Partida-Sanchez S, Rivero-Nava L, Shi G, Lund FE: CD38: An ecto-enzyme at the
ing B lymphocytes from patients with chronic lymphocytic leukemia. J Exp Med 169: crossroads of innate and adaptive immune responses. Adv Exp Med Biol 590:171–183,
255–268, 1989. 2007.
42. Anderson KC, Park EK, Bates MP, et al: Antigens on human plasma cells identified by 75. Kumar V, Sharma A: Adenosine: An endogenous modulator of innate immune system
monoclonal antibodies. J Immunol 130:1132–1138, 1983. with therapeutic potential. Eur J Pharmacol 616:7–15, 2009.
43. Rawstron AC: Immunophenotyping of plasma cells. Curr Protoc Cytom Chapter 6: 76. Plamboeck A, Holst JJ, Carr RD, Deacon CF: Neutral endopeptidase 24.11 and dipepti-
Unit6.23, 2006. dyl peptidase IV are both involved in regulating the metabolic stability of glucagon-like
44. Keegan AD, Paul WE: Multichain immune recognition receptors: Similarities in struc- peptide-1 in vivo. Adv Exp Med Biol 524:303–312, 2003.
ture and signaling pathways. Immunol Today 13:63–68, 1992. 77. Ohnuma K, Takahashi N, Yamochi T, et al: Role of CD26/dipeptidyl peptidase IV in
45. Maddon PJ, Littman DR, Godfrey M, et al: The isolation and nucleotide sequence of a human T cell activation and function. Front Biosci 13:2299–2310, 2008.
cDNA encoding the T cell surface protein T4: A new member of the immunoglobulin 78. Yamamoto S, Higuchi Y, Yoshiyama K, et al: ADAM family proteins in the immune
gene family. Cell 42:93–104, 1985. system. Immunol Today 20:278–284, 1999.
46. Snow PM, Terhorst C: The T8 antigen is a multimeric complex of two distinct subun- 79. Black RA: Tumor necrosis factor-alpha converting enzyme. Int J Biochem Cell Biol
its on human thymocytes but consists of homomultimeric forms on peripheral blood 34:1–5, 2002.
T lymphocytes. J Biol Chem 258:14675–14681, 1983. 80. Lindvall JM, Blomberg KE, Väliaho J, et al: Bruton’s tyrosine kinase: Cell biology,
47. Dalgleish AG, Beverley PC, Clapham PR, et al: The CD4 (T4) antigen is an essential sequence conservation, mutation spectrum, siRNA modifications, and expression pro-
component of the receptor for the AIDS retrovirus. Nature 312:763–767, 1984. filing. Immunol Rev 203:200–215, 2005.
48. Sakaguchi S, Yamaguchi T, Nomura T, Ono M: Regulatory T cells and immune toler- 81. Kurosaki T, Hikida M: Tyrosine kinases and their substrates in B lymphocytes. Immu-
ance. Cell 133:775–787, 2008. nol Rev 228:132–148, 2009.
49. Roncador G, Brown PJ, Maestre L, et al: Analysis of FOXP3 protein expression in 82. Au-Yeung BB, Deindl S, Hsu LY, et al: The structure, regulation, function of ZAP-70.
human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 35:1681– Immunol Rev 228:41–57, 2009.
1691, 2005. 83. Salmond RJ, Filby A, Qureshi I, et al: T-cell receptor proximal signaling via the Src-
50. Grogg KL, Attygalle AD, Macon WR, et al: Expression of CXCL13, a chemokine highly family kinases, Lck and Fyn, influences T-cell activation, differentiation, and tolerance.
upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell Immunol Rev 228:9–22, 2009.
lymphoma from peripheral T-cell lymphoma, unspecified. Mod Pathol 19:1101–1107, 2006. 84. Leo A, Schraven B: Adapters in lymphocyte signalling. Curr Opin Immunol 13:307–316,
51. Yang Y, Torchinsky MB, Gobert M, et al: Focused specificity of intestinal TH17 cells 2001.
towards commensal bacterial antigens. Nature 510:152–156, 2014. 85. Tsukada S, Baba Y, Watanabe D: Btk and BLNK in B cell development. Adv Immunol
52. Timonen T, Saksela E: Isolation of human NK cells by density gradient centrifugation. 77:123–162, 2001.
J Immunol Methods 36:285–291, 1980. 86. Aguado E, Martinez-Florensa M, Aparicio P: Activation of T lymphocytes and the role
53. Hercend T, Griffin JD, Bensussan A, et al: Generation of monoclonal antibodies to a of the adapter LAT. Transpl Immunol 17:23–26, 2006.
human natural killer clone. Characterization of two natural killer-associated antigens, 87. Rey M, Sanchez-Madrid F, Valenzuela-Fernandez A: The role of actomyosin and the
NKH1A and NKH2, expressed on subsets of large granular lymphocytes. J Clin Invest microtubular network in both the immunological synapse and T cell activation. Front
75:932–943, 1985. Biosci 12:437–447, 2007.
54. Cooper MA, Fehniger TA, Caligiuri MA: The biology of human natural killer-cell sub- 88. Miletic AV, Swat M, Fujikawa K, Swat W: Cytoskeletal remodeling in lymphocyte acti-
sets. Trends Immunol 22:633–640, 2001. vation. Curr Opin Immunol 15:261–268, 2003.
55. Björkström NK, Gonzalez VD, Malmberg KJ, et al: Elevated numbers of Fc gamma 89. Glen AC: Measurement of DNA and RNA in human peripheral blood lymphocytes.
RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C Clin Chem 13:299–313, 1967.
virus infection. J Immunol 181:4219–4228, 2008. 90. Beaumelle BD, Gibson A, Hopkins CR: Isolation and preliminary characterization of
56. Lanier LL, Le AM, Phillips JH, et al: Subpopulations of human natural killer cells the major membrane boundaries of the endocytic pathway in lymphocytes. J Cell Biol
defined by expression of the Leu-7 (HNK-1) and Leu-11 (NK-15) antigens. J Immunol 111:1811–1823, 1990.
131:1789–1796, 1983. 91. Casey TM, Meade JL, Hewitt EW: Organelle proteomics: Identification of the exocytic
57. Thiel A, Scheffold A, Radbruch A: Antigen-specific cytometry—New tools arrived! Clin machinery associated with the natural killer cell secretory lysosome. Mol Cell Proteomics
Immunol 111:155–161, 2004. 6:767–780, 2007.
58. Kodituwakku AP, Jessup C, Zola H, Roberton DM: Isolation of antigen-specific B cells. 92. Qu P, Du H, Wilkes DS, Yan C: Critical roles of lysosomal acid lipase in T cell develop-
Immunol Cell Biol 81:163–170, 2003. ment and function. Am J Pathol 174:944–956, 2009.
59. Kinoshita K, Ozawa T, Tajiri K, et al: Identification of antigen-specific B cells by concur- 93. Kulenkampff J, Janossy G, Greaves MF: Acid esterase in human lymphoid cells and
rent monitoring of intracellular Ca2+ mobilization and antigen binding with microwell leukaemic blasts: A marker for T lymphocytes. Br J Haematol 36:231–240, 1977.
array chip system equipped with a CCD imager. Cytometry A 75:682–687, 2009. 94. Lettau M, Schmidt H, Kabelitz D, Janssen O: Secretory lysosomes and their cargo in
60. Segel GB, Cokelet GR, Lichtman MA: The measurement of lymphocyte volume: T and NK cells. Immunol Lett 108:10–19, 2007.
importance of reference particle deformability and counting solution tonicity. Blood 57: 95. Chavez-Galan L, Arenas-Del Angel MC, Zenteno E, et al: Cell death mechanisms
894–899, 1981. induced by cytotoxic lymphocytes. Cell Mol Immunol 6:15–25, 2009.
61. Lichtman AH, Segel GB, Lichtman MA: An ultrasensitive method for the measurement 96. Bots M, Medema JP: Serpins in T cell immunity. J Leukoc Biol 84:1238–1247, 2008.
of human leukocyte calcium: Lymphocytes. Clin Chim Acta 97:107–121, 1979. 97. Trapani JA, Smyth MJ: Functional significance of the perforin/granzyme cell death
62. Komada H, Nakabayashi H, Nakano H, et al: Measurement of the cytosolic free calcium pathway. Nat Rev Immunol 2:735–747, 2002.
ion concentration of individual lymphocytes by microfluorometry using quin 2 or fura- 98. Pham CT, Ley TJ: Dipeptidyl peptidase I is required for the processing and activation of
2. Cell Struct Funct 14:141–150, 1989. granzymes A and B in vivo. Proc Natl Acad Sci U S A 96:8627–8632, 1999.

Kaushansky_chapter 73_p1135-1148.indd 1146 9/21/15 4:45 PM